Is TXG overvalued right now?
A stock is overvalued when its market price sits above a reasonable fair value range. Use the live snapshot on this page for TXG, then validate with fundamentals and peer multiples.
10x Genomics, Inc. (TXG) is currently Undervalued by 135.30%
Instant valuation answer
10x Genomics, Inc. (TXG) appears undervalued by approximately 135.30% based on our live valuation percent and intrinsic value estimate derived from DCF, P/E Multiple, and P/S Multiple models. Valuation can still differ across analyst models, growth expectations, and risk assumptions.
- Upside (live) 135.30% (from live valuation API)
- Confidence (live) 9.5/10 (Very High)
Confidence Score is based on the magnitude of upside or downside vs intrinsic value.
Fair value estimate
Unlock fair valueCurrent price
$37.83
Stock valuation checker
Search our company database (same as the site header). Choose a result or type a ticker and press Check valuation.
Explore Our Valuation Calculators
Why is 10x Genomics, Inc. overvalued or undervalued?
Intrinsic value work anchors 10x Genomics, Inc. on owner earnings and balance-sheet capacity; the current quote trades below that anchor, which frames the stock as relatively cheap on a fundamentals-first view.
Versus historical valuation bands, TXG is closer to the lower end of where this business has traded when profitability and growth were comparable—useful context before reading any single headline multiple.
Forward market expectations are muted: the price does not require heroic assumptions to converge with our fair-value zone, but sector peers and macro rates still deserve a quick sanity check on the company page.
Key metrics
- P/E ratio
- 48.1x
- Revenue growth (TTM y/y)
- 23%
- Profit margin
- 11.7%
- Fair value (model)
- Unlock
Frequently asked questions — TXG
What is 10x Genomics, Inc.'s intrinsic value?
Our DCF, P/E Multiple, and P/S Multiple models estimate whether TXG trades above or below fair value. At $37.83, 10x Genomics, Inc. currently looks undervalued on this snapshot. Tickerplace Pro unlocks the full dollar fair value estimate.
How is 10x Genomics, Inc.'s intrinsic value calculated?
Tickerplace calculates TXG's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to flag undervalued or overvalued positioning.
Is TXG undervalued right now?
Based on our 2026 valuation models, 10x Genomics, Inc. (TXG) appears undervalued at $37.83 with about 135.3% upside to fair value. Treat this as a screen—verify fundamentals on the company profile.
Related companies — valuation
Peers for TXG: open their overvalued / undervalued view.